

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.37846111 |
| 2 | amino sugar catabolic process (GO:0046348) | 5.17547936 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.96976618 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.96976618 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.96976618 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.96976618 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.96976618 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.96976618 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.94016083 |
| 10 | cellular response to exogenous dsRNA (GO:0071360) | 4.93927635 |
| 11 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.75552250 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 4.67253829 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.62822310 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 4.61275327 |
| 15 | * glycosphingolipid catabolic process (GO:0046479) | 4.54210227 |
| 16 | response to peptidoglycan (GO:0032494) | 4.50881490 |
| 17 | regulation of cholesterol storage (GO:0010885) | 4.40515861 |
| 18 | respiratory burst (GO:0045730) | 4.39752705 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 4.37186841 |
| 20 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.35152236 |
| 21 | cellular response to interferon-alpha (GO:0035457) | 4.33091643 |
| 22 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.10687561 |
| 23 | regulation of mononuclear cell migration (GO:0071675) | 4.06820870 |
| 24 | * glycolipid catabolic process (GO:0019377) | 4.02411590 |
| 25 | cellular response to interferon-beta (GO:0035458) | 3.99238560 |
| 26 | positive regulation of T cell chemotaxis (GO:0010820) | 3.97858847 |
| 27 | regulation of T cell chemotaxis (GO:0010819) | 3.97858847 |
| 28 | interferon-gamma secretion (GO:0072643) | 3.96367819 |
| 29 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.87852905 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.86344711 |
| 31 | T-helper 1 type immune response (GO:0042088) | 3.85325404 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.84050249 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.82822399 |
| 34 | response to thyroid hormone (GO:0097066) | 3.79340999 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.77977416 |
| 36 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.77641635 |
| 37 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.76752970 |
| 38 | microglial cell activation (GO:0001774) | 3.74826423 |
| 39 | granulocyte activation (GO:0036230) | 3.67493298 |
| 40 | neutrophil activation (GO:0042119) | 3.66925410 |
| 41 | * oligosaccharide catabolic process (GO:0009313) | 3.66162000 |
| 42 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.59669731 |
| 43 | reactive oxygen species biosynthetic process (GO:1903409) | 3.59451936 |
| 44 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.58817472 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.55094679 |
| 46 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.54108350 |
| 47 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.52430804 |
| 48 | pinocytosis (GO:0006907) | 3.52113069 |
| 49 | * ceramide catabolic process (GO:0046514) | 3.51221597 |
| 50 | superoxide anion generation (GO:0042554) | 3.48568640 |
| 51 | N-acetylneuraminate metabolic process (GO:0006054) | 3.47484554 |
| 52 | positive regulation of leukocyte degranulation (GO:0043302) | 3.46732548 |
| 53 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.45011771 |
| 54 | positive regulation of T cell migration (GO:2000406) | 3.44254407 |
| 55 | B cell mediated immunity (GO:0019724) | 3.42650011 |
| 56 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.40681828 |
| 57 | regulation of monocyte chemotaxis (GO:0090025) | 3.39502917 |
| 58 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.38376932 |
| 59 | cytokine secretion (GO:0050663) | 3.36239657 |
| 60 | regulation of RIG-I signaling pathway (GO:0039535) | 3.34245814 |
| 61 | response to interferon-alpha (GO:0035455) | 3.34182526 |
| 62 | intracellular pH reduction (GO:0051452) | 3.30406941 |
| 63 | detection of other organism (GO:0098543) | 3.30394171 |
| 64 | positive regulation of interferon-beta production (GO:0032728) | 3.26707504 |
| 65 | response to interferon-beta (GO:0035456) | 3.24005852 |
| 66 | positive regulation of lymphocyte migration (GO:2000403) | 3.23852336 |
| 67 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.22429466 |
| 68 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.22336967 |
| 69 | response to host immune response (GO:0052572) | 3.22336967 |
| 70 | myeloid cell activation involved in immune response (GO:0002275) | 3.21871516 |
| 71 | barbed-end actin filament capping (GO:0051016) | 3.21193262 |
| 72 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.20893852 |
| 73 | defense response to protozoan (GO:0042832) | 3.20390694 |
| 74 | positive regulation of mast cell activation (GO:0033005) | 3.19907428 |
| 75 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.19814172 |
| 76 | regulation of podosome assembly (GO:0071801) | 3.19263376 |
| 77 | regulation of chemokine biosynthetic process (GO:0045073) | 3.18606268 |
| 78 | osteoclast differentiation (GO:0030316) | 3.18579846 |
| 79 | protein localization to endosome (GO:0036010) | 3.16690250 |
| 80 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.16615768 |
| 81 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.15651983 |
| 82 | positive regulation of mast cell degranulation (GO:0043306) | 3.15651983 |
| 83 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.15107769 |
| 84 | cellular extravasation (GO:0045123) | 3.14814357 |
| 85 | leukocyte mediated cytotoxicity (GO:0001909) | 3.14576434 |
| 86 | regulation of antigen processing and presentation (GO:0002577) | 3.14379788 |
| 87 | regulation of mast cell degranulation (GO:0043304) | 3.12922418 |
| 88 | glucosamine-containing compound catabolic process (GO:1901072) | 3.10748933 |
| 89 | lymphocyte mediated immunity (GO:0002449) | 3.10372548 |
| 90 | * membrane lipid catabolic process (GO:0046466) | 3.09065581 |
| 91 | monocyte chemotaxis (GO:0002548) | 3.08685111 |
| 92 | positive regulation of cholesterol efflux (GO:0010875) | 3.08366111 |
| 93 | macrophage activation (GO:0042116) | 3.08058913 |
| 94 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.06992185 |
| 95 | positive regulation of interleukin-12 production (GO:0032735) | 3.04809606 |
| 96 | regulation of mast cell activation (GO:0033003) | 3.04716116 |
| 97 | regulation of superoxide anion generation (GO:0032928) | 3.04665137 |
| 98 | natural killer cell mediated immunity (GO:0002228) | 3.04646981 |
| 99 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.04646981 |
| 100 | cellular response to type I interferon (GO:0071357) | 3.03798702 |
| 101 | type I interferon signaling pathway (GO:0060337) | 3.03798702 |
| 102 | detection of external biotic stimulus (GO:0098581) | 3.03559015 |
| 103 | regulation of B cell differentiation (GO:0045577) | 3.03412200 |
| 104 | apoptotic cell clearance (GO:0043277) | 3.01292638 |
| 105 | response to protozoan (GO:0001562) | 3.01186395 |
| 106 | detection of bacterium (GO:0016045) | 3.01084305 |
| 107 | regulation of T cell migration (GO:2000404) | 3.00658486 |
| 108 | NIK/NF-kappaB signaling (GO:0038061) | 2.99442406 |
| 109 | regulation of leukocyte degranulation (GO:0043300) | 2.99156559 |
| 110 | dendritic cell differentiation (GO:0097028) | 2.97961855 |
| 111 | regulation of vitamin metabolic process (GO:0030656) | 2.96879970 |
| 112 | response to type I interferon (GO:0034340) | 2.96814580 |
| 113 | positive regulation of bone resorption (GO:0045780) | 2.96694853 |
| 114 | positive regulation of bone remodeling (GO:0046852) | 2.96694853 |
| 115 | regulation of lymphocyte migration (GO:2000401) | 2.94788442 |
| 116 | * sphingolipid catabolic process (GO:0030149) | 2.93731835 |
| 117 | T cell migration (GO:0072678) | 2.92031900 |
| 118 | mannose metabolic process (GO:0006013) | 2.91915940 |
| 119 | peptide catabolic process (GO:0043171) | 2.91098860 |
| 120 | response to muramyl dipeptide (GO:0032495) | 2.91040262 |
| 121 | keratan sulfate catabolic process (GO:0042340) | 2.90487613 |
| 122 | regulation of macrophage chemotaxis (GO:0010758) | 2.89438684 |
| 123 | virion attachment to host cell (GO:0019062) | 2.89222625 |
| 124 | adhesion of symbiont to host cell (GO:0044650) | 2.89222625 |
| 125 | eosinophil chemotaxis (GO:0048245) | 2.89170548 |
| 126 | actin nucleation (GO:0045010) | 2.88217299 |
| 127 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.88146318 |
| 128 | phagosome maturation (GO:0090382) | 2.87847581 |
| 129 | germinal center formation (GO:0002467) | 2.86393795 |
| 130 | mast cell activation (GO:0045576) | 2.85508613 |
| 131 | regulation of monocyte differentiation (GO:0045655) | 2.84596142 |
| 132 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.84218313 |
| 133 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.83408665 |
| 134 | lipoxygenase pathway (GO:0019372) | 2.83358032 |
| 135 | negative regulation of interleukin-17 production (GO:0032700) | 2.82311076 |
| 136 | positive regulation of type 2 immune response (GO:0002830) | 2.81302311 |
| 137 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.80425310 |
| 138 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.80104237 |
| 139 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.80058519 |
| 140 | positive regulation of tissue remodeling (GO:0034105) | 2.79740182 |
| 141 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.78651663 |
| 142 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.77436952 |
| 143 | cellular response to zinc ion (GO:0071294) | 2.76824055 |
| 144 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.76391575 |
| 145 | response to host (GO:0075136) | 2.76391575 |
| 146 | response to host defenses (GO:0052200) | 2.76391575 |
| 147 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.75730489 |
| 148 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.75730489 |
| 149 | myeloid dendritic cell activation (GO:0001773) | 2.75279820 |
| 150 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.74877246 |
| 151 | detection of molecule of bacterial origin (GO:0032490) | 2.74417855 |
| 152 | negative regulation of mast cell activation (GO:0033004) | 2.74272648 |
| 153 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.74247195 |
| 154 | myeloid dendritic cell differentiation (GO:0043011) | 2.72567783 |
| 155 | myeloid leukocyte activation (GO:0002274) | 2.71896056 |
| 156 | regulation of activation of Janus kinase activity (GO:0010533) | 2.70700861 |
| 157 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.70379082 |
| 158 | regulation of growth of symbiont in host (GO:0044126) | 2.69371301 |
| 159 | negative regulation of growth of symbiont in host (GO:0044130) | 2.69371301 |
| 160 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.69371301 |
| 161 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.66707024 |
| 162 | decidualization (GO:0046697) | 2.66667097 |
| 163 | adhesion of symbiont to host (GO:0044406) | 2.66562711 |
| 164 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.66477734 |
| 165 | macrophage differentiation (GO:0030225) | 2.65910222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.24990994 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.50550767 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.47866085 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.20492578 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.04836300 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.42311701 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.25118500 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.23860847 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05279483 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.01260367 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.95543975 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.88823689 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.77958966 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.61953352 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.58708121 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.43750073 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.40867021 |
| 18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.29352376 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.28603005 |
| 20 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.18679344 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.04442503 |
| 22 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.02543013 |
| 23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90653430 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88038826 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.86619150 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85412672 |
| 27 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78783736 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.78130881 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.70992366 |
| 30 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70089325 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.65579705 |
| 32 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61498490 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.57204545 |
| 34 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.56044799 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51898505 |
| 36 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.51746397 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49877028 |
| 38 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.49156750 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.48365363 |
| 40 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46971579 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44482610 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.44377835 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42348554 |
| 44 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42203955 |
| 45 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42065172 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.41825630 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.39025916 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38958479 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36136765 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.35758450 |
| 51 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.33874278 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33446243 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31958787 |
| 54 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31895753 |
| 55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31778296 |
| 56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31095584 |
| 57 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.30712770 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29168234 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27961586 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25554819 |
| 61 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.24435897 |
| 62 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.22817410 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22388330 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22134584 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21723325 |
| 66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.20003548 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19874360 |
| 68 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18559732 |
| 69 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17510281 |
| 70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17202847 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15535820 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14335625 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14115459 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14035404 |
| 75 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.11123725 |
| 76 | MYC_22102868_ChIP-Seq_BL_Human | 1.08397168 |
| 77 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07966017 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06956997 |
| 79 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05492926 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05215630 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05076279 |
| 82 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.04491190 |
| 83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.04456671 |
| 84 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03585647 |
| 85 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03393262 |
| 86 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00996544 |
| 87 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97716017 |
| 88 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95329370 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95226616 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95122556 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90536261 |
| 92 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.90527144 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88823263 |
| 94 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.88677333 |
| 95 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88382845 |
| 96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88281963 |
| 97 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87289209 |
| 98 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.87283782 |
| 99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87256620 |
| 100 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86844765 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85451760 |
| 102 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.85307967 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.83829119 |
| 104 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83550717 |
| 105 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83508209 |
| 106 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83508209 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83059526 |
| 108 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82979260 |
| 109 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82432846 |
| 110 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.81239658 |
| 111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80886992 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80633392 |
| 113 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79581090 |
| 114 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.78530128 |
| 115 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.77726823 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76284425 |
| 117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.75904700 |
| 118 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.74777804 |
| 119 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.74125216 |
| 120 | UTX_26944678_Chip-Seq_JUKART_Human | 0.73248998 |
| 121 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72519467 |
| 122 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.72137300 |
| 123 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.70909089 |
| 124 | MAF_26560356_Chip-Seq_TH2_Human | 0.70351258 |
| 125 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.69469979 |
| 126 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.69186165 |
| 127 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.67512622 |
| 128 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.66715477 |
| 129 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.66619591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.77481130 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 3.73614307 |
| 3 | MP0003436_decreased_susceptibility_to | 3.51276116 |
| 4 | MP0009785_altered_susceptibility_to | 3.37880675 |
| 5 | MP0005671_abnormal_response_to | 3.04215299 |
| 6 | MP0002419_abnormal_innate_immunity | 3.01798140 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.92185083 |
| 8 | MP0005025_abnormal_response_to | 2.89837696 |
| 9 | MP0006082_CNS_inflammation | 2.85163681 |
| 10 | MP0001853_heart_inflammation | 2.65156366 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.58303948 |
| 12 | MP0000685_abnormal_immune_system | 2.53693983 |
| 13 | MP0009840_abnormal_foam_cell | 2.51572340 |
| 14 | MP0001790_abnormal_immune_system | 2.49970436 |
| 15 | MP0005387_immune_system_phenotype | 2.49970436 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.40325844 |
| 17 | MP0003195_calcinosis | 2.34083676 |
| 18 | MP0001800_abnormal_humoral_immune | 2.30832950 |
| 19 | MP0002723_abnormal_immune_serum | 2.29436342 |
| 20 | MP0003724_increased_susceptibility_to | 2.28739613 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.24921829 |
| 22 | MP0001819_abnormal_immune_cell | 2.23358806 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.15187641 |
| 24 | MP0003303_peritoneal_inflammation | 2.06114499 |
| 25 | MP0004510_myositis | 2.02674320 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.88634648 |
| 27 | MP0003329_amyloid_beta_deposits | 1.86296742 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.75508106 |
| 29 | MP0003453_abnormal_keratinocyte_physiol | 1.73638676 |
| 30 | MP0009764_decreased_sensitivity_to | 1.71124906 |
| 31 | MP0002405_respiratory_system_inflammati | 1.70644503 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.68388831 |
| 33 | MP0002006_tumorigenesis | 1.67698958 |
| 34 | MP0000343_altered_response_to | 1.62436289 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.61241477 |
| 36 | MP0008469_abnormal_protein_level | 1.60446300 |
| 37 | MP0002877_abnormal_melanocyte_morpholog | 1.59226693 |
| 38 | MP0004782_abnormal_surfactant_physiolog | 1.57871036 |
| 39 | MP0003186_abnormal_redox_activity | 1.56931425 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.56631284 |
| 41 | MP0000716_abnormal_immune_system | 1.53282572 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.51014204 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.49660503 |
| 44 | MP0005310_abnormal_salivary_gland | 1.48881011 |
| 45 | MP0003448_altered_tumor_morphology | 1.46410314 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 1.42948536 |
| 47 | MP0002398_abnormal_bone_marrow | 1.42806215 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.41176909 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.39969805 |
| 50 | MP0003075_altered_response_to | 1.35312572 |
| 51 | MP0008260_abnormal_autophagy | 1.32012515 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.29541413 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.29541413 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.29391016 |
| 55 | MP0002254_reproductive_system_inflammat | 1.28504107 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.28468472 |
| 57 | MP0002429_abnormal_blood_cell | 1.24520089 |
| 58 | MP0000858_altered_metastatic_potential | 1.23140296 |
| 59 | MP0000920_abnormal_myelination | 1.23000385 |
| 60 | MP0004019_abnormal_vitamin_homeostasis | 1.22855955 |
| 61 | MP0004947_skin_inflammation | 1.22366867 |
| 62 | MP0002722_abnormal_immune_system | 1.18783012 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.17489765 |
| 64 | MP0005365_abnormal_bile_salt | 1.16668736 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.14563900 |
| 66 | MP0010234_abnormal_vibrissa_follicle | 1.14501294 |
| 67 | MP0003690_abnormal_glial_cell | 1.13111921 |
| 68 | MP0004381_abnormal_hair_follicle | 1.12532203 |
| 69 | MP0008004_abnormal_stomach_pH | 1.12194490 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 1.11450344 |
| 71 | MP0006054_spinal_hemorrhage | 1.06148638 |
| 72 | MP0003866_abnormal_defecation | 1.05277447 |
| 73 | MP0005166_decreased_susceptibility_to | 1.03329705 |
| 74 | MP0002090_abnormal_vision | 1.00319652 |
| 75 | MP0009278_abnormal_bone_marrow | 1.00060853 |
| 76 | MP0003091_abnormal_cell_migration | 0.98422460 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 0.95912009 |
| 78 | MP0009763_increased_sensitivity_to | 0.94983629 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.91014361 |
| 80 | MP0005165_increased_susceptibility_to | 0.86843353 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 0.86827057 |
| 82 | MP0001881_abnormal_mammary_gland | 0.86705516 |
| 83 | MP0000490_abnormal_crypts_of | 0.85985300 |
| 84 | MP0000604_amyloidosis | 0.85891898 |
| 85 | MP0005647_abnormal_sex_gland | 0.84136923 |
| 86 | MP0003693_abnormal_embryo_hatching | 0.83536650 |
| 87 | MP0003634_abnormal_glial_cell | 0.82812169 |
| 88 | MP0005164_abnormal_response_to | 0.82315658 |
| 89 | MP0004883_abnormal_blood_vessel | 0.80685503 |
| 90 | MP0003763_abnormal_thymus_physiology | 0.80605467 |
| 91 | MP0000627_abnormal_mammary_gland | 0.78214987 |
| 92 | MP0000371_diluted_coat_color | 0.77820843 |
| 93 | MP0002796_impaired_skin_barrier | 0.77781661 |
| 94 | MP0002396_abnormal_hematopoietic_system | 0.77379498 |
| 95 | MP0003795_abnormal_bone_structure | 0.76970162 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.76076799 |
| 97 | MP0001216_abnormal_epidermal_layer | 0.75848904 |
| 98 | MP0000249_abnormal_blood_vessel | 0.75704484 |
| 99 | MP0010307_abnormal_tumor_latency | 0.75346854 |
| 100 | MP0001764_abnormal_homeostasis | 0.74370722 |
| 101 | MP0005332_abnormal_amino_acid | 0.73242536 |
| 102 | MP0001851_eye_inflammation | 0.73119667 |
| 103 | MP0005023_abnormal_wound_healing | 0.71456640 |
| 104 | MP0002168_other_aberrant_phenotype | 0.70724407 |
| 105 | MP0001756_abnormal_urination | 0.70019182 |
| 106 | MP0001849_ear_inflammation | 0.69923449 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.69679174 |
| 108 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69087340 |
| 109 | MP0000383_abnormal_hair_follicle | 0.68953180 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.68827861 |
| 111 | MP0005390_skeleton_phenotype | 0.68302731 |
| 112 | MP0008057_abnormal_DNA_replication | 0.66380524 |
| 113 | MP0003828_pulmonary_edema | 0.66045068 |
| 114 | MP0001542_abnormal_bone_strength | 0.65880013 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.65860795 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.65685989 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.65372502 |
| 118 | MP0010352_gastrointestinal_tract_polyps | 0.65190122 |
| 119 | MP0003632_abnormal_nervous_system | 0.64383415 |
| 120 | MP0005395_other_phenotype | 0.64299097 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.63009339 |
| 122 | MP0001958_emphysema | 0.62039683 |
| 123 | MP0008874_decreased_physiological_sensi | 0.61549244 |
| 124 | MP0000569_abnormal_digit_pigmentation | 0.61284426 |
| 125 | MP0003279_aneurysm | 0.60674216 |
| 126 | MP0000609_abnormal_liver_physiology | 0.60148177 |
| 127 | MP0000598_abnormal_liver_morphology | 0.59498370 |
| 128 | MP0005174_abnormal_tail_pigmentation | 0.58762686 |
| 129 | MP0004808_abnormal_hematopoietic_stem | 0.58753044 |
| 130 | MP0003705_abnormal_hypodermis_morpholog | 0.58691715 |
| 131 | MP0001727_abnormal_embryo_implantation | 0.58541065 |
| 132 | MP0002009_preneoplasia | 0.55895643 |
| 133 | MP0005451_abnormal_body_composition | 0.54847446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.29124369 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.93708929 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.50405244 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.03102031 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.91850688 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 4.84631990 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.82767655 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.54601028 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.39642965 |
| 10 | Obstructive lung disease (HP:0006536) | 4.39642965 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 4.37017322 |
| 12 | Neurofibrillary tangles (HP:0002185) | 4.22664603 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.19146169 |
| 14 | Myositis (HP:0100614) | 3.92812777 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.92076240 |
| 16 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.82740109 |
| 17 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.82740109 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.82740109 |
| 19 | Mutism (HP:0002300) | 3.78297175 |
| 20 | Mucopolysacchariduria (HP:0008155) | 3.71195344 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.71195344 |
| 22 | Optic neuritis (HP:0100653) | 3.71144039 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.71144039 |
| 24 | Orchitis (HP:0100796) | 3.60532331 |
| 25 | Recurrent skin infections (HP:0001581) | 3.52627245 |
| 26 | Basal ganglia calcification (HP:0002135) | 3.34972468 |
| 27 | Vasculitis (HP:0002633) | 3.32802366 |
| 28 | Gingivitis (HP:0000230) | 3.19981544 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.18644356 |
| 30 | Cerebral inclusion bodies (HP:0100314) | 3.08739421 |
| 31 | Recurrent fungal infections (HP:0002841) | 3.05412036 |
| 32 | Nuclear cataract (HP:0100018) | 3.04776681 |
| 33 | Loss of speech (HP:0002371) | 3.01276882 |
| 34 | Pustule (HP:0200039) | 2.99282966 |
| 35 | Meningitis (HP:0001287) | 2.98360160 |
| 36 | Petechiae (HP:0000967) | 2.98204956 |
| 37 | Upper motor neuron abnormality (HP:0002127) | 2.95402358 |
| 38 | Prolonged neonatal jaundice (HP:0006579) | 2.89577598 |
| 39 | Neuronal loss in central nervous system (HP:0002529) | 2.87831017 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.84852509 |
| 41 | Nephritis (HP:0000123) | 2.84054162 |
| 42 | Increased IgM level (HP:0003496) | 2.81483128 |
| 43 | Periodontitis (HP:0000704) | 2.80196578 |
| 44 | Pulmonary infiltrates (HP:0002113) | 2.76597252 |
| 45 | Abnormality of complement system (HP:0005339) | 2.73960854 |
| 46 | Metaphyseal irregularity (HP:0003025) | 2.65333706 |
| 47 | Hepatosplenomegaly (HP:0001433) | 2.63995955 |
| 48 | Axonal loss (HP:0003447) | 2.63680155 |
| 49 | Recurrent viral infections (HP:0004429) | 2.62257274 |
| 50 | Interstitial pulmonary disease (HP:0006530) | 2.62065297 |
| 51 | Glomerulonephritis (HP:0000099) | 2.61335958 |
| 52 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.60172651 |
| 53 | Hemoptysis (HP:0002105) | 2.59271429 |
| 54 | Anorexia (HP:0002039) | 2.59221281 |
| 55 | Inappropriate behavior (HP:0000719) | 2.57173786 |
| 56 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.56844777 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 2.55691263 |
| 58 | Chronic otitis media (HP:0000389) | 2.55098424 |
| 59 | Arterial thrombosis (HP:0004420) | 2.53986956 |
| 60 | IgM deficiency (HP:0002850) | 2.52174733 |
| 61 | Cerebral palsy (HP:0100021) | 2.52115322 |
| 62 | Nausea (HP:0002018) | 2.50747833 |
| 63 | Joint hemorrhage (HP:0005261) | 2.49857667 |
| 64 | Progressive neurologic deterioration (HP:0002344) | 2.48909616 |
| 65 | Urticaria (HP:0001025) | 2.47588154 |
| 66 | Global brain atrophy (HP:0002283) | 2.46109841 |
| 67 | Progressive visual loss (HP:0000529) | 2.45457848 |
| 68 | Cellulitis (HP:0100658) | 2.44629911 |
| 69 | Abnormality of the periventricular white matter (HP:0002518) | 2.44050687 |
| 70 | Personality changes (HP:0000751) | 2.42698919 |
| 71 | Stomatitis (HP:0010280) | 2.39972066 |
| 72 | Abnormality of the pleura (HP:0002103) | 2.38923073 |
| 73 | Recurrent pneumonia (HP:0006532) | 2.36026485 |
| 74 | Leukocytosis (HP:0001974) | 2.35697859 |
| 75 | Gingival bleeding (HP:0000225) | 2.34829995 |
| 76 | Myocardial infarction (HP:0001658) | 2.34006812 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 2.32332010 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 2.29532097 |
| 79 | Keratoconjunctivitis (HP:0001096) | 2.29362578 |
| 80 | Increased serum ferritin (HP:0003281) | 2.29079783 |
| 81 | Agnosia (HP:0010524) | 2.28902001 |
| 82 | Glomerulopathy (HP:0100820) | 2.28732912 |
| 83 | Eosinophilia (HP:0001880) | 2.26804101 |
| 84 | Granulocytopenia (HP:0001913) | 2.23197727 |
| 85 | Azoospermia (HP:0000027) | 2.21120209 |
| 86 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.19838208 |
| 87 | Recurrent cutaneous fungal infections (HP:0011370) | 2.19838208 |
| 88 | Dysostosis multiplex (HP:0000943) | 2.18774988 |
| 89 | Thick nail (HP:0001805) | 2.16426988 |
| 90 | Abnormality of eosinophils (HP:0001879) | 2.15917135 |
| 91 | Cardiomegaly (HP:0001640) | 2.15625032 |
| 92 | Abnormality of the pericardium (HP:0001697) | 2.15540276 |
| 93 | * Diminished motivation (HP:0000745) | 2.14143523 |
| 94 | Osteolytic defects of the hand bones (HP:0009699) | 2.13285456 |
| 95 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13285456 |
| 96 | * Apathy (HP:0000741) | 2.13277995 |
| 97 | Protuberant abdomen (HP:0001538) | 2.12787175 |
| 98 | Peripheral demyelination (HP:0011096) | 2.12423901 |
| 99 | Thoracic kyphosis (HP:0002942) | 2.10821575 |
| 100 | Abnormality of the prostate (HP:0008775) | 2.09938012 |
| 101 | Xanthomatosis (HP:0000991) | 2.08886705 |
| 102 | * Dementia (HP:0000726) | 2.08780482 |
| 103 | Encephalitis (HP:0002383) | 2.08479929 |
| 104 | Amyloidosis (HP:0011034) | 2.08106359 |
| 105 | Recurrent lower respiratory tract infections (HP:0002783) | 2.07364690 |
| 106 | Cheilitis (HP:0100825) | 2.05826690 |
| 107 | Purpura (HP:0000979) | 2.05815830 |
| 108 | Supranuclear gaze palsy (HP:0000605) | 2.05148081 |
| 109 | * Poor head control (HP:0002421) | 2.04379875 |
| 110 | Pulmonary fibrosis (HP:0002206) | 2.02469519 |
| 111 | Complement deficiency (HP:0004431) | 2.01010692 |
| 112 | Skin rash (HP:0000988) | 1.99852117 |
| 113 | Retinal atrophy (HP:0001105) | 1.99422311 |
| 114 | Increased CSF protein (HP:0002922) | 1.99228063 |
| 115 | Thrombocytosis (HP:0001894) | 1.99213562 |
| 116 | Hematochezia (HP:0002573) | 1.99097554 |
| 117 | Bone pain (HP:0002653) | 1.98522176 |
| 118 | Multiple enchondromatosis (HP:0005701) | 1.97440986 |
| 119 | Osteomyelitis (HP:0002754) | 1.96731250 |
| 120 | * Abnormality of glycolipid metabolism (HP:0010969) | 1.96712351 |
| 121 | * Abnormality of liposaccharide metabolism (HP:0010968) | 1.96712351 |
| 122 | * Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96712351 |
| 123 | Acrocyanosis (HP:0001063) | 1.96054100 |
| 124 | Prostate neoplasm (HP:0100787) | 1.95080023 |
| 125 | Disinhibition (HP:0000734) | 1.93331060 |
| 126 | Skin ulcer (HP:0200042) | 1.92342099 |
| 127 | IgA deficiency (HP:0002720) | 1.90562773 |
| 128 | Pathologic fracture (HP:0002756) | 1.88835854 |
| 129 | Septate vagina (HP:0001153) | 1.87698368 |
| 130 | Premature loss of primary teeth (HP:0006323) | 1.87602450 |
| 131 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84928595 |
| 132 | Restrictive lung disease (HP:0002091) | 1.84424943 |
| 133 | Polyneuropathy (HP:0001271) | 1.83748513 |
| 134 | Vertebral compression fractures (HP:0002953) | 1.83596796 |
| 135 | Skin nodule (HP:0200036) | 1.82980358 |
| 136 | IgG deficiency (HP:0004315) | 1.82336768 |
| 137 | T lymphocytopenia (HP:0005403) | 1.81900492 |
| 138 | Exertional dyspnea (HP:0002875) | 1.77189249 |
| 139 | Esophageal varix (HP:0002040) | 1.77093040 |
| 140 | Malnutrition (HP:0004395) | 1.76551973 |
| 141 | Abnormality of iron homeostasis (HP:0011031) | 1.74339952 |
| 142 | Neoplasm of head and neck (HP:0012288) | 1.72561499 |
| 143 | Esophageal neoplasm (HP:0100751) | 1.72561499 |
| 144 | Increased IgE level (HP:0003212) | 1.72422864 |
| 145 | Gangrene (HP:0100758) | 1.71084485 |
| 146 | Abnormality of the lumbar spine (HP:0100712) | 1.70425143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 4.31671984 |
| 2 | MAP3K14 | 4.27196841 |
| 3 | IRAK3 | 3.95825592 |
| 4 | BLK | 3.95218866 |
| 5 | IRAK4 | 3.44419611 |
| 6 | RIPK4 | 3.21622490 |
| 7 | MAP4K1 | 3.10403897 |
| 8 | TBK1 | 2.71815834 |
| 9 | TYK2 | 2.68582361 |
| 10 | PBK | 2.62583634 |
| 11 | PIM2 | 2.56345195 |
| 12 | PRPF4B | 2.39874288 |
| 13 | DDR2 | 2.38078067 |
| 14 | TXK | 2.35920590 |
| 15 | IKBKB | 2.34241516 |
| 16 | NEK9 | 2.05873884 |
| 17 | JAK3 | 1.98963987 |
| 18 | MAP3K3 | 1.91637870 |
| 19 | KIT | 1.83525912 |
| 20 | IKBKE | 1.78285162 |
| 21 | ARAF | 1.77969838 |
| 22 | MAP3K12 | 1.76560379 |
| 23 | CSF1R | 1.76376324 |
| 24 | RIPK1 | 1.72798733 |
| 25 | PIM1 | 1.64132661 |
| 26 | MST4 | 1.61221063 |
| 27 | MOS | 1.60366600 |
| 28 | BMPR2 | 1.52162099 |
| 29 | JAK1 | 1.50957906 |
| 30 | CDC42BPA | 1.48655229 |
| 31 | WEE1 | 1.47676797 |
| 32 | ZAP70 | 1.43770416 |
| 33 | SYK | 1.43634342 |
| 34 | TAOK1 | 1.40054534 |
| 35 | CSK | 1.32090998 |
| 36 | CHUK | 1.29837916 |
| 37 | BTK | 1.28280886 |
| 38 | CAMK1D | 1.28054970 |
| 39 | ABL2 | 1.25505889 |
| 40 | LYN | 1.21573907 |
| 41 | TEC | 1.21154884 |
| 42 | ZAK | 1.20061335 |
| 43 | MAP3K13 | 1.19156708 |
| 44 | MATK | 1.16065646 |
| 45 | EIF2AK1 | 1.15669264 |
| 46 | BUB1 | 1.13505310 |
| 47 | PLK4 | 1.12344382 |
| 48 | MAP3K1 | 1.10108646 |
| 49 | CAMKK2 | 1.09156703 |
| 50 | TESK2 | 1.08010104 |
| 51 | NME2 | 1.01887602 |
| 52 | STK4 | 0.99947981 |
| 53 | STK24 | 0.96464954 |
| 54 | HCK | 0.95184559 |
| 55 | STK16 | 0.86119656 |
| 56 | JAK2 | 0.84364212 |
| 57 | PRKCD | 0.82926051 |
| 58 | CDK6 | 0.82294750 |
| 59 | MARK3 | 0.81695236 |
| 60 | TAOK3 | 0.80102153 |
| 61 | LCK | 0.77287073 |
| 62 | CLK1 | 0.76552569 |
| 63 | FES | 0.75849396 |
| 64 | RPS6KA2 | 0.75713490 |
| 65 | FLT3 | 0.74793014 |
| 66 | EIF2AK2 | 0.72337896 |
| 67 | TESK1 | 0.72159588 |
| 68 | ERBB3 | 0.71437391 |
| 69 | BMX | 0.71414994 |
| 70 | TRPM7 | 0.71138768 |
| 71 | YES1 | 0.70879385 |
| 72 | IRAK2 | 0.70446557 |
| 73 | PDGFRA | 0.69395536 |
| 74 | LRRK2 | 0.65664422 |
| 75 | MAP2K6 | 0.65374006 |
| 76 | MAP3K5 | 0.64350556 |
| 77 | MYLK | 0.63194118 |
| 78 | MAP2K3 | 0.62450312 |
| 79 | FGFR3 | 0.61880644 |
| 80 | FGFR4 | 0.61373445 |
| 81 | TTN | 0.61109455 |
| 82 | EPHB1 | 0.60069732 |
| 83 | STK10 | 0.59874249 |
| 84 | LIMK1 | 0.59862994 |
| 85 | IRAK1 | 0.59609651 |
| 86 | KDR | 0.57095844 |
| 87 | ERN1 | 0.56479300 |
| 88 | TRIB3 | 0.56339796 |
| 89 | SIK3 | 0.56258511 |
| 90 | CAMK1G | 0.56114118 |
| 91 | ITK | 0.55596665 |
| 92 | KSR2 | 0.54423137 |
| 93 | PIK3CG | 0.52212595 |
| 94 | ABL1 | 0.52064078 |
| 95 | GRK1 | 0.50250113 |
| 96 | TGFBR1 | 0.49955923 |
| 97 | PAK4 | 0.46952356 |
| 98 | LATS2 | 0.46848617 |
| 99 | TGFBR2 | 0.45368557 |
| 100 | ICK | 0.45029518 |
| 101 | MAP3K8 | 0.44821430 |
| 102 | MAPK4 | 0.43434613 |
| 103 | MAPK7 | 0.43085238 |
| 104 | MAP3K9 | 0.43008036 |
| 105 | EIF2AK3 | 0.42497651 |
| 106 | GRK7 | 0.40542002 |
| 107 | PRKCQ | 0.40496192 |
| 108 | MAPKAPK2 | 0.40197829 |
| 109 | STK3 | 0.40063069 |
| 110 | NUAK1 | 0.39273549 |
| 111 | MAPK12 | 0.38474413 |
| 112 | RPS6KA4 | 0.38206548 |
| 113 | RPS6KA6 | 0.37317538 |
| 114 | ADRBK2 | 0.35089712 |
| 115 | TYRO3 | 0.35067144 |
| 116 | PDGFRB | 0.34913372 |
| 117 | PDK2 | 0.34446548 |
| 118 | SGK3 | 0.34355088 |
| 119 | PDK1 | 0.33729029 |
| 120 | MAP3K6 | 0.33462655 |
| 121 | FYN | 0.33183676 |
| 122 | MST1R | 0.32354884 |
| 123 | MAP3K11 | 0.31910317 |
| 124 | FGR | 0.31382532 |
| 125 | PRKG2 | 0.31028970 |
| 126 | GRK6 | 0.30846349 |
| 127 | INSR | 0.30459220 |
| 128 | MAP3K2 | 0.29534013 |
| 129 | TAOK2 | 0.29470019 |
| 130 | RPS6KC1 | 0.26283866 |
| 131 | RPS6KL1 | 0.26283866 |
| 132 | RPS6KB2 | 0.25750138 |
| 133 | ACVR1B | 0.23342633 |
| 134 | NEK6 | 0.23041398 |
| 135 | PDPK1 | 0.22549966 |
| 136 | AKT3 | 0.22077925 |
| 137 | BRAF | 0.18604239 |
| 138 | RAF1 | 0.18412627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.09846040 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90971785 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.79429545 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.70173464 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.62655791 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.51088299 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.48759416 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.36153508 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.34067647 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.32060080 |
| 11 | * Lysosome_Homo sapiens_hsa04142 | 2.30970501 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.29856850 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.20894714 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.02276844 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.95908568 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.94423920 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.84740639 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.84559768 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.82690410 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81250290 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.74733985 |
| 22 | Salmonella infection_Homo sapiens_hsa05132 | 1.70403369 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.66913267 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.62395327 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.61007333 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54380697 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.48643930 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.42077616 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.41724352 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.40798671 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.38627208 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.38515416 |
| 33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.34573593 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.28366452 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23634897 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23466801 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.23346394 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20589121 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.17124689 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.11147571 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10838225 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.10100920 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08872021 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.08376546 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.08361280 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08337820 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07003704 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04216222 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96347886 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94894644 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94547057 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93223297 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91669224 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89505040 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88456876 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84065491 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83034138 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.81413708 |
| 59 | Bladder cancer_Homo sapiens_hsa05219 | 0.78898883 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.78395016 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78335678 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.76297546 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71480816 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68113085 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66782226 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66526213 |
| 67 | Hepatitis B_Homo sapiens_hsa05161 | 0.66177066 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63374896 |
| 69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61821579 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61733958 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61039200 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60487459 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58544195 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57612382 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56964339 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54860523 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54158182 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52202330 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51430352 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51371934 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51055192 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49431585 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48622798 |
| 84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46984473 |
| 85 | DNA replication_Homo sapiens_hsa03030 | 0.46807867 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46096903 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45739667 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44389400 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44137196 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43772021 |
| 91 | Homologous recombination_Homo sapiens_hsa03440 | 0.43587642 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.43513438 |
| 93 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42367001 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41402489 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38900663 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.38703667 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38564798 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37905347 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37142757 |
| 100 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.36606441 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35938307 |
| 102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35373609 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.35366302 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.35272351 |
| 105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35119217 |
| 106 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.32387977 |
| 107 | Base excision repair_Homo sapiens_hsa03410 | 0.32143541 |
| 108 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.31564742 |
| 109 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31128747 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30563304 |
| 111 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.29447815 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29349574 |
| 113 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.28344648 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28319049 |
| 115 | RNA polymerase_Homo sapiens_hsa03020 | 0.27967319 |
| 116 | Protein export_Homo sapiens_hsa03060 | 0.27948598 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.27779292 |
| 118 | Platelet activation_Homo sapiens_hsa04611 | 0.27778407 |
| 119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.26597061 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25316232 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.23767734 |
| 122 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23331356 |
| 123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22849331 |
| 124 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.18487356 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17885509 |

